Help appealing denials for this monthly PCSK9 inhibitor for high LDL cholesterol.

Appeal Your Lerochol Denial

Get access to this once-monthly injectable for lowering LDL cholesterol.

Understanding Your Lerochol (lerodalcibep) Denial

Lerochol (lerodalcibep) is a PCSK9 inhibitor approved as an adjunct to diet and exercise for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). Unlike other PCSK9 inhibitors, it's dosed once monthly. Insurance often denies PCSK9 inhibitors due to high cost, but these medications are essential for patients who cannot reach LDL goals with statins alone.

Common Reasons for Denial

! Must try maximum-tolerated statin first
! LDL goal not defined or documented
! Prior authorization required
! Preferred PCSK9 inhibitor required
! Documentation of statin intolerance inadequate
! High-cost specialty medication

How We Help

We help you document your LDL levels, statin history (including intolerance if applicable), cardiovascular risk factors, and why achieving LDL goals is critical for your health.

Start your Lerochol appeal — it takes about 3 minutes.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ PCSK9 inhibitors significantly reduce LDL cholesterol by 50-60% and decrease cardiovascular events in high-risk patients.

✓ Patients with familial hypercholesterolemia often cannot reach LDL goals with statins alone and benefit from PCSK9 inhibitor therapy.

✓ Lower LDL cholesterol levels are associated with reduced risk of heart attack, stroke, and cardiovascular death.

✓ Once-monthly dosing may improve medication adherence compared to more frequent injection schedules.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

LIB Therapeutics Patient Support

Patient assistance program information will be available at launch (Spring 2026). LIB Therapeutics is committed to ensuring broad access to LEROCHOL.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Frequently Asked Questions

Coverage criteria vary by insurer, but typically require LDL of 70-100 mg/dL or higher despite maximum-tolerated statin therapy, especially for patients with established cardiovascular disease or familial hypercholesterolemia.

Document your statin intolerance (muscle pain, elevated liver enzymes, etc.) and which statins you've tried. PCSK9 inhibitors are particularly important for statin-intolerant patients who still need aggressive LDL lowering.

Ready to Fight Your Lerochol (lerodalcibep) Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including LIB Therapeutics. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.